Next-Generation Contraceptives Market - A Global and Regional Analysis: Focus on Gender, Offering, End User, and Region - Analysis and Forecast, 2024-2033
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
This report will be delivered in 7-10 working days.
The global next-generation contraceptives market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecasts that a decision-maker can take advantage of.
The market study encompasses a detailed examination of various next-generation contraceptives including technological advancements, and market dynamics. It explores the market based on segmentations such as by gender, and by offering and by distribution channel and highlights the competitive landscape, profiling key players and their strategies for market expansion. The report delves into regional segmentation, evaluating market performance across different geographical areas. Additionally, it discusses the impact of macroeconomic factors on market growth and explores potential investment opportunities for stakeholders.
With a focus on fostering a deep understanding of market dynamics, the report serves as a valuable resource for businesses, investors, and industry participants seeking strategic insights into the evolving global next-generation contraceptives market.
Market Segmentation
Segmentation 1: by Gender
This report will be delivered in 7-10 working days.
The global next-generation contraceptives market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecasts that a decision-maker can take advantage of.
The market study encompasses a detailed examination of various next-generation contraceptives including technological advancements, and market dynamics. It explores the market based on segmentations such as by gender, and by offering and by distribution channel and highlights the competitive landscape, profiling key players and their strategies for market expansion. The report delves into regional segmentation, evaluating market performance across different geographical areas. Additionally, it discusses the impact of macroeconomic factors on market growth and explores potential investment opportunities for stakeholders.
With a focus on fostering a deep understanding of market dynamics, the report serves as a valuable resource for businesses, investors, and industry participants seeking strategic insights into the evolving global next-generation contraceptives market.
Market Segmentation
Segmentation 1: by Gender
- Male
- Female
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
- Others
- Drugs
- Devices
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- Latin America
- What are the major market drivers, challenges, and opportunities in the global next-generation contraceptives market and their case studies?
- How will the next-generation contraceptives market evolve and what is its scope in the future?
- What is the market share of the leading segments and sub-segments of the global next-generation contraceptives market?
- How will each segment of the global next-generation contraceptives market grow during the forecast period?
- What are the key developmental strategies implemented by the key players to stand out in this market?
Executive Summary
Scope and Definition
Market/Product Definition
Key Questions Answered
Analysis and Forecast Note
1 MARKETS: INDUSTRY OUTLOOK
1.1 Trends: Current and Future Impact Assessment
1.2 Supply Chain Overview
1.2.1 Value chain Analysis
1.2.2 Market Map
1.3 R&D Review
1.3.1 Patent Filing Trend by Country, by Company
1.4 Regulatory Landscape
1.5 Market Dynamics Overview
1.5.1 Market Drivers
1.5.2 Market Restraints
1.5.3 Market Opportunities
2 NEXT-GENERATION CONTRACEPTIVES MARKET BY APPLICATION
2.1 Application Segmentation
2.2 Application Summary
2.3 Global Next-Generation Contraceptives Market, by Gender
2.3.1 Male
2.3.2 Female
2.4 Global Next-Generation Contraceptives Market, by End User
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Channels
2.4.4 Others
3 NEXT-GENERATION CONTRACEPTIVES MARKET BY PRODUCT TYPE
3.1 Product Segmentation
3.2 Product Summary
3.3 Global Next-Generation Contraceptives Market, by Offering
3.3.1 Drugs
3.3.1.1 Contraceptive Pills
3.3.1.2 Injectables
3.3.1.3 Patches
3.3.1.4 Others
3.3.2 Devices
3.3.2.1 Condoms
3.3.2.2 Vaginal Rings
3.3.2.3 Intra-uterine Devices
3.3.2.4 Others
4 NEXT-GENERATION CONTRACEPTIVES MARKET BY REGION
4.1 Regional Summary
4.2 Drivers and Restraints as you go along…
4.3 North America
4.3.1 Markets
4.3.1.1 Key Market Participants in North America
4.3.1.2 Business Drivers
4.3.1.3 Business Challenges
4.3.2 North America Next Generation Contraceptives Market, by End User
4.3.3 North America by Country
4.3.3.1 U.S.
4.3.3.2 Canada
4.4 Europe
4.4.1 Markets
4.4.1.1 Key Market Participants in Europe
4.4.1.2 Business Drivers
4.4.1.3 Business Challenges
4.4.2 Europe Next Generation Contraceptives Market, by End User
4.4.3 Europe by Country
4.4.3.1 U.K.
4.4.3.2 Germany
4.4.3.3 France
4.4.3.4 Italy
4.4.3.5 Spain
4.4.3.6 Rest of Europe
4.5 Asia-Pacific
4.5.1 Markets
4.5.1.1 Key Market Participants in Asia-Pacific
4.5.1.2 Business Drivers
4.5.1.3 Business Challenges
4.5.2 Asia-Pacific America Next Generation Contraceptives Market, by End User
4.5.3 Asia-Pacific by Country
4.5.3.1 China
4.5.3.2 Japan
4.5.3.3 India
4.5.3.4 South Korea
4.5.3.5 Rest of Asia-Pacific
4.6 Latin America
4.6.1 Markets
4.6.1.1 Key Market Participants in Latin America
4.6.1.2 Business Drivers
4.6.1.3 Business Challenges
4.6.2 Latin America Next Generation Contraceptives Market, by End User
4.6.3 Latin America by Country
4.6.3.1 Brazil
4.6.3.2 Mexico
4.6.3.3 Rest of Latin America
4.7 Middle East and Africa
4.7.1 Markets
4.7.1.1 Key Market Participants in Middle East and Africa
4.7.1.2 Business Drivers
4.7.1.3 Business Challenges
4.7.2 Middle East and Africa Next Generation Contraceptives Market, by End User
5 MARKETS – COMPETITIVE LANDSCAPE & COMPANY PROFILES
5.1 Competitive Landscape
5.2 Company Profiles
5.2.1 AbbVie
5.2.1.1 Company Overview
5.2.1.2 Top Products / Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Target Customers /End-Users
5.2.1.5 Key Personnel
5.2.1.6 Analyst View
5.2.2 Bayer Corporation
5.2.2.1 Company Overview
5.2.2.2 Top Products / Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Target Customers /End-Users
5.2.2.5 Key Personnel
5.2.2.6 Analyst View
5.2.3 Cooper Surgical, Inc.
5.2.3.1 Company Overview
5.2.3.2 Top Products / Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Target Customers /End-Users
5.2.3.5 Key Personnel
5.2.3.6 Analyst View
5.2.4 Church & Dwight Co, Inc.
5.2.4.1 Company Overview
5.2.4.2 Top Products / Product Portfolio
5.2.4.3 Top Competitors
5.2.4.4 Target Customers /End-Users
5.2.4.5 Key Personnel
5.2.4.6 Analyst View
5.2.5 Merck & Co Inc.
5.2.5.1 Company Overview
5.2.5.2 Top Products / Product Portfolio
5.2.5.3 Top Competitors
5.2.5.4 Target Customers /End-Users
5.2.5.5 Key Personnel
5.2.5.6 Analyst View
5.2.6 Pfizer
5.2.6.1 Company Overview
5.2.6.2 Top Products / Product Portfolio
5.2.6.3 Top Competitors
5.2.6.4 Target Customers /End-Users
5.2.6.5 Key Personnel
5.2.6.6 Analyst View
5.2.7 Reckitt Benckiser Group Plc
5.2.7.1 Company Overview
5.2.7.2 Top Products / Product Portfolio
5.2.7.3 Top Competitors
5.2.7.4 Target Customers /End-Users
5.2.7.5 Key Personnel
5.2.7.6 Analyst View
5.2.8 Teva Pharmaceuticals Industries Ltd.
5.2.8.1 Company Overview
5.2.8.2 Top Products / Product Portfolio
5.2.8.3 Top Competitors
5.2.8.4 Target Customers /End-Users
5.2.8.5 Key Personnel
5.2.8.6 Analyst View
5.2.9 The Female Health Company/Veru Inc.
5.2.9.1 Company Overview
5.2.9.2 Top Products / Product Portfolio
5.2.9.3 Top Competitors
5.2.9.4 Target Customers /End-Users
5.2.9.5 Key Personnel
5.2.9.6 Analyst View
5.2.10 Afaxys, Inc
5.2.10.1 Company Overview
5.2.10.2 Top Products / Product Portfolio
5.2.10.3 Top Competitors
5.2.10.4 Target Customers /End-Users
5.2.10.5 Key Personnel
5.2.10.6 Analyst View
5.2.11 Aditxt
5.2.11.1 Company Overview
5.2.11.2 Top Products / Product Portfolio
5.2.11.3 Top Competitors
5.2.11.4 Target Customers /End-Users
5.2.11.5 Key Personnel
5.2.11.6 Analyst View
5.2.12 Darй Bioscience, Inc
5.2.12.1 Company Overview
5.2.12.2 Top Products / Product Portfolio
5.2.12.3 Top Competitors
5.2.12.4 Target Customers /End-Users
5.2.12.5 Key Personnel
5.2.12.6 Analyst View
5.2.13 TherapeuticsMD, Inc
5.2.13.1 Company Overview
5.2.13.2 Top Products / Product Portfolio
5.2.13.3 Top Competitors
5.2.13.4 Target Customers /End-Users
5.2.13.5 Key Personnel
5.2.13.6 Analyst View
5.2.14 Other Companies
6 RESEARCH METHODOLOGY
Scope and Definition
Market/Product Definition
Key Questions Answered
Analysis and Forecast Note
1 MARKETS: INDUSTRY OUTLOOK
1.1 Trends: Current and Future Impact Assessment
1.2 Supply Chain Overview
1.2.1 Value chain Analysis
1.2.2 Market Map
1.3 R&D Review
1.3.1 Patent Filing Trend by Country, by Company
1.4 Regulatory Landscape
1.5 Market Dynamics Overview
1.5.1 Market Drivers
1.5.2 Market Restraints
1.5.3 Market Opportunities
2 NEXT-GENERATION CONTRACEPTIVES MARKET BY APPLICATION
2.1 Application Segmentation
2.2 Application Summary
2.3 Global Next-Generation Contraceptives Market, by Gender
2.3.1 Male
2.3.2 Female
2.4 Global Next-Generation Contraceptives Market, by End User
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Channels
2.4.4 Others
3 NEXT-GENERATION CONTRACEPTIVES MARKET BY PRODUCT TYPE
3.1 Product Segmentation
3.2 Product Summary
3.3 Global Next-Generation Contraceptives Market, by Offering
3.3.1 Drugs
3.3.1.1 Contraceptive Pills
3.3.1.2 Injectables
3.3.1.3 Patches
3.3.1.4 Others
3.3.2 Devices
3.3.2.1 Condoms
3.3.2.2 Vaginal Rings
3.3.2.3 Intra-uterine Devices
3.3.2.4 Others
4 NEXT-GENERATION CONTRACEPTIVES MARKET BY REGION
4.1 Regional Summary
4.2 Drivers and Restraints as you go along…
4.3 North America
4.3.1 Markets
4.3.1.1 Key Market Participants in North America
4.3.1.2 Business Drivers
4.3.1.3 Business Challenges
4.3.2 North America Next Generation Contraceptives Market, by End User
4.3.3 North America by Country
4.3.3.1 U.S.
4.3.3.2 Canada
4.4 Europe
4.4.1 Markets
4.4.1.1 Key Market Participants in Europe
4.4.1.2 Business Drivers
4.4.1.3 Business Challenges
4.4.2 Europe Next Generation Contraceptives Market, by End User
4.4.3 Europe by Country
4.4.3.1 U.K.
4.4.3.2 Germany
4.4.3.3 France
4.4.3.4 Italy
4.4.3.5 Spain
4.4.3.6 Rest of Europe
4.5 Asia-Pacific
4.5.1 Markets
4.5.1.1 Key Market Participants in Asia-Pacific
4.5.1.2 Business Drivers
4.5.1.3 Business Challenges
4.5.2 Asia-Pacific America Next Generation Contraceptives Market, by End User
4.5.3 Asia-Pacific by Country
4.5.3.1 China
4.5.3.2 Japan
4.5.3.3 India
4.5.3.4 South Korea
4.5.3.5 Rest of Asia-Pacific
4.6 Latin America
4.6.1 Markets
4.6.1.1 Key Market Participants in Latin America
4.6.1.2 Business Drivers
4.6.1.3 Business Challenges
4.6.2 Latin America Next Generation Contraceptives Market, by End User
4.6.3 Latin America by Country
4.6.3.1 Brazil
4.6.3.2 Mexico
4.6.3.3 Rest of Latin America
4.7 Middle East and Africa
4.7.1 Markets
4.7.1.1 Key Market Participants in Middle East and Africa
4.7.1.2 Business Drivers
4.7.1.3 Business Challenges
4.7.2 Middle East and Africa Next Generation Contraceptives Market, by End User
5 MARKETS – COMPETITIVE LANDSCAPE & COMPANY PROFILES
5.1 Competitive Landscape
5.2 Company Profiles
5.2.1 AbbVie
5.2.1.1 Company Overview
5.2.1.2 Top Products / Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Target Customers /End-Users
5.2.1.5 Key Personnel
5.2.1.6 Analyst View
5.2.2 Bayer Corporation
5.2.2.1 Company Overview
5.2.2.2 Top Products / Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Target Customers /End-Users
5.2.2.5 Key Personnel
5.2.2.6 Analyst View
5.2.3 Cooper Surgical, Inc.
5.2.3.1 Company Overview
5.2.3.2 Top Products / Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Target Customers /End-Users
5.2.3.5 Key Personnel
5.2.3.6 Analyst View
5.2.4 Church & Dwight Co, Inc.
5.2.4.1 Company Overview
5.2.4.2 Top Products / Product Portfolio
5.2.4.3 Top Competitors
5.2.4.4 Target Customers /End-Users
5.2.4.5 Key Personnel
5.2.4.6 Analyst View
5.2.5 Merck & Co Inc.
5.2.5.1 Company Overview
5.2.5.2 Top Products / Product Portfolio
5.2.5.3 Top Competitors
5.2.5.4 Target Customers /End-Users
5.2.5.5 Key Personnel
5.2.5.6 Analyst View
5.2.6 Pfizer
5.2.6.1 Company Overview
5.2.6.2 Top Products / Product Portfolio
5.2.6.3 Top Competitors
5.2.6.4 Target Customers /End-Users
5.2.6.5 Key Personnel
5.2.6.6 Analyst View
5.2.7 Reckitt Benckiser Group Plc
5.2.7.1 Company Overview
5.2.7.2 Top Products / Product Portfolio
5.2.7.3 Top Competitors
5.2.7.4 Target Customers /End-Users
5.2.7.5 Key Personnel
5.2.7.6 Analyst View
5.2.8 Teva Pharmaceuticals Industries Ltd.
5.2.8.1 Company Overview
5.2.8.2 Top Products / Product Portfolio
5.2.8.3 Top Competitors
5.2.8.4 Target Customers /End-Users
5.2.8.5 Key Personnel
5.2.8.6 Analyst View
5.2.9 The Female Health Company/Veru Inc.
5.2.9.1 Company Overview
5.2.9.2 Top Products / Product Portfolio
5.2.9.3 Top Competitors
5.2.9.4 Target Customers /End-Users
5.2.9.5 Key Personnel
5.2.9.6 Analyst View
5.2.10 Afaxys, Inc
5.2.10.1 Company Overview
5.2.10.2 Top Products / Product Portfolio
5.2.10.3 Top Competitors
5.2.10.4 Target Customers /End-Users
5.2.10.5 Key Personnel
5.2.10.6 Analyst View
5.2.11 Aditxt
5.2.11.1 Company Overview
5.2.11.2 Top Products / Product Portfolio
5.2.11.3 Top Competitors
5.2.11.4 Target Customers /End-Users
5.2.11.5 Key Personnel
5.2.11.6 Analyst View
5.2.12 Darй Bioscience, Inc
5.2.12.1 Company Overview
5.2.12.2 Top Products / Product Portfolio
5.2.12.3 Top Competitors
5.2.12.4 Target Customers /End-Users
5.2.12.5 Key Personnel
5.2.12.6 Analyst View
5.2.13 TherapeuticsMD, Inc
5.2.13.1 Company Overview
5.2.13.2 Top Products / Product Portfolio
5.2.13.3 Top Competitors
5.2.13.4 Target Customers /End-Users
5.2.13.5 Key Personnel
5.2.13.6 Analyst View
5.2.14 Other Companies
6 RESEARCH METHODOLOGY
